Cargando…
Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
Autores principales: | Okhovat, Ali Asghar, Fatehi, Farzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874893/ http://dx.doi.org/10.18502/cjn.v19i2.4945 |
Ejemplares similares
-
Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise
por: Ali, Hassam, et al.
Publicado: (2021) -
Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases
por: Karimi, Narges, et al.
Publicado: (2021) -
A retrospective study of the safety and efficacy of rituximab in Iranian patients with myasthenia gravis: A single-center experience
por: Ziaadini, Bentolhoda, et al.
Publicado: (2022) -
Muscle-Specific Kinase Myasthenia Gravis
por: Borges, Lucia S., et al.
Publicado: (2020) -
Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity
por: Shin, Ha Young, et al.
Publicado: (2014)